KalpSetu
Export lanes › Medicines (tablets and capsules) › Myanmar

Export medicines (tablets and capsules) from India to Myanmar: duty, documents and price

HS 3004.90 (medicaments in measured doses, tablets and capsules) · duty checked 18 Nov 2026 · documents checked 18 Nov 2026

Duty: basic duty 1.5%, ASEAN–India Trade in Goods Agreement is in force; the preferential rate for this HS code is not confirmed. Directional

Documents: Importer-Exporter Code (IEC), Myanmar FDA drug registration, Certificate of Analysis, Commercial invoice, plus 19 more listed below. Directional

What Myanmar charges

ItemRate
Basic (MFN) duty1.5%
Preferential ratenot confirmed
ASEAN–India Trade in Goods Agreement (in force 2010-01-01)
VAT / GST at importnot confirmed

Directional Source: basic duty: WITS https://wits.worldbank.org/API/V1/SDMX/V21/datasource/TRN/reporter/104/partner/000/product/300490/year/all/datatype/reported. Reported tariff for 2023 (WITS), not checked against today's schedule; verify before committing. Not established: VAT/GST, FTA rate. Basic duty is the applied MFN rate Myanmar reported to WITS (UNCTAD TRAINS) for 2023, not today's schedule. No anti-dumping, safeguard, or CBAM measure could be established for HS 300490 from the available official tariff information. Confirm with Myanmar customs before pricing a deal.

Documents and registrations

Where to get them: IEC and any DGFT export authorisation: Directorate General of Foreign Trade (DGFT); RCMC: Pharmaceuticals Export Promotion Council of India (Pharmexcil), an authority listed by DGFT for pharmaceutical products; pharmaceutical manufacturing licence and GMP certificate: the relevant Indian State Licensing Authority or Central Drugs Standard Control Organization (CDSCO), as applicable; Certificate of Pharmaceutical Product: CDSCO or the competent Indian drug-control authority; Certificate of Origin: authorised chamber of commerce or other authorised issuing agency; Certificate of Analysis: the manufacturer's quality-control laboratory or an officially accepted accredited laboratory; Myanmar drug registration, import licence and product-specific approvals: Myanmar Food and Drug Administration (Myanmar FDA); shipping bill and export declaration: Indian Customs through the Indian Customs EDI system

The exact Indian restriction, inspection and certificate package depends on the product's ITC(HS) code, formulation, controlled-substance status and the Myanmar FDA's product-specific approval; a generic pharmaceutical export should not be treated as automatically requiring a DGFT export licence or universal pre-shipment inspection. Shipments commonly fail when the Myanmar FDA registration or import approval does not match the product, strength, manufacturer, batch and label, or when the invoice, packing list, certificates and transport documents contain inconsistent details.

Directional Compiled for pharmaceuticals exports to Myanmar from the official pages below, checked 18 Nov 2026. Confirm with the issuing authority.
https://content.dgft.gov.in/Website/dgftprod/6978673f-9c59-4aac-a612-084df7b47e39/HBP2023_Chapter02.pdf
https://www.dgft.gov.in/CP/?opt=e-rcmc
https://content.dgft.gov.in/Website/HTE.pdf
https://content.dgft.gov.in/Website/dgftprod/5a7b48fd-e5a3-4656-8c7a-6716c656f6f5/2T_Updated.pdf

What this page does not know

Save this lane to My Trades and work on it

Opens in the KalpSetu portal. Sign in with Google to save it: 30 days of Growth free, no card.

Open in the portal

Grades: Real is read from an official or primary source on the date shown. Directional is an estimate, a compilation or a single unconfirmed source. Reference is an official schedule or rule.